Cite

HARVARD Citation

    Zenzeri, L. et al. (n.d.). Efficacy of adalimumab as first-line therapy in pediatric Crohn's disease. Digestive and liver disease. 49 (4), pp. e261-. [Online]. 
  
Back to record